Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Critical Reviews in Microbiology|April 19, 2023
Long-Term effects of COVID-19: a review of current perspectives and mechanistic insightsChristian Lenz, Mary P E Slack, Kimberly M Shea, et al.
Pathogens (Basel, Switzerland)|May 28, 2020
Characteristics of Serotype 3 Invasive Pneumococcal Disease before and after Universal Childhood Immunization with PCV13 in MassachusettsRotem Lapidot, Kimberly M Shea, Inci Yildirim, et al.
Cost Effectiveness and Resource Allocation : C/E|April 30, 2024
Impact of including productivity costs in economic analyses of vaccines for C. difficile infections and infant respiratory syncytial virus, in a UK settingMargherita Neri, Janne C Mewes, Fernando Albuquerque de Almeida, et al.
BMC Infectious Diseases|October 31, 2015
Rates of pneumonia among children and adults with chronic medical conditions in GermanyStephen I Pelton, Kimberly M Shea, Raymond A Farkouh, et al.
Scientific Reports|September 11, 2021
Continued need for non-pharmaceutical interventions after COVID-19 vaccination in long-term-care facilitiesJay Love, Lindsay T Keegan, Frederick J Angulo, et al.
Annals of Intensive Care|August 17, 2018
Ten-year trends in intensive care admissions for respiratory infections in the elderlyLucile Laporte, Coralie Hermetet, Youenn Jouan, et al.
Expert Review of Vaccines|May 13, 2025
Potential public health and economic impact of maternal vaccination with bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine for the prevention of acute respiratory infection among infants in the United StatesAhuva Averin, Amy W Law, Derek Weycker, et al.
Vaccine|October 30, 2010
Serotype specific invasive capacity and persistent reduction in invasive pneumococcal diseaseInci Yildirim, William P Hanage, Marc Lipsitch, et al.
Vaccines|May 25, 2024
Healthcare Providers' and Pregnant People's Preferences for a Preventive to Protect Infants from Serious Illness Due to Respiratory Syncytial VirusKathleen M Beusterien, Amy W Law, Martine C Maculaitis, et al.
Human Vaccines & Immunotherapeutics|June 7, 2024
A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United StatesMartine C Maculaitis, Brett Hauber, Kathleen M Beusterien, et al.
Pageof 4